Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2011-12-09

Clinical Trial Update: Presbyopia in Breast Cancer Survivors

View source ↗

Summary

A clinical trial investigating presbyopia in breast cancer survivors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Alberta Health services | Conditions: Presbyopia | Status: WITHDRAWN